Reply: More Stents, More Troubles
We have read with a particular attention the letter titled “More stent, more troubles” by Dinesch and Buruian where they, commenting our case report [1], argue the lack of scientific evidence to support the treatment of chronic total occlusion (CTO). (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 31, 2016 Category: Cardiology Authors: Giuseppe Talanas, Roberto Garbo Source Type: research

The Challenge of Percutaneous Coronary Intervention in Small Vessels
Significant coronary artery disease (CAD) occurring in small vessels (typically defined as (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 31, 2016 Category: Cardiology Authors: Joshua P. Loh, Rajiv Ananthakrishna Tags: Editorial Source Type: research

CRT 20/20 brings innovation to practice
The objective of the first meeting, held in Washington, DC on February 18, 1997, was to introduce a new technology to the field of interventional cardiology: vascular brachytherapy. At that time, we were combating in-stent restenosis of bare metal stents and high restenosis rates following treatment of de novo lesions with balloon angioplasty. The quest for an effective therapy to prevent or treat restenosis led to the breakthrough of vascular brachytherapy, which was emerging as an effective and safe solution to a lingering problem. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 31, 2016 Category: Cardiology Authors: Ron Waksman Tags: Editorial Source Type: research

Percutaneous coronary intervention of chronically occluded saphenous vein grafts using excimer laser atherectomy as an adjuvant therapy.
We present two cases with chronic total occlusion of the saphenous vein graft in two patients with a history of previous bypass surgery with unfavourable anatomic features for recanalization of the native coronary artery. In the first case, two dedicated attempts for recanalization of chronic total occlusion of the native artery failed and in the second case there was not an adequate visualization of the native vessel beyond the occlusion point, not even by contralateral injection. Excimer laser atherectomy was used in both cases as an adjuvant therapy during recanalization of the saphenous vein graft in combination with a...
Source: Cardiovascular Revascularization Medicine - December 26, 2016 Category: Cardiology Authors: Mohsen Mohandes, Sergio Rojas, Mauricio Torres, Cristina Moreno, Francisco Fern ández, Jordi Guarinos, Alfredo Bardají Source Type: research

Image noise reduction technology reduces radiation in a radial-first cardiac catheterization laboratory
Transradial coronary angiography (TRA) has been associated with increased radiation doses. We hypothesized that contemporary image noise reduction technology would reduce radiation doses in the cardiac catheterization laboratory in a typical clinical setting. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 26, 2016 Category: Cardiology Authors: Ateka Gunja, Yagya Pandey, Hui Xie, Beata M. Wolska, Adhir R. Shroff, Amer K. Ardati, Mladen I. Vidovich Source Type: research

Lipid-Core Burden Response to Stent Implantation assessed with Near-Infrared Spectroscopy and Intravascular Ultrasound evaluation in Patients with myocardial Infarction
Near-infrared spectroscopy (NIRS) is a new method to identify lipid core plaque (LCP). The LCP and vascular response were assessed with NIRS to examine whether LCP was compressed or redistributed during percutaneous coronary intervention with stent implantation. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 26, 2016 Category: Cardiology Authors: Manijeh Noori, Per Thayssen, Karsten Tange Veien, Anders Junker, Knud N ørregaard Hansen, Henrik Steen Hansen, Lisette Okkels Jensen Source Type: research

Mitral Stenosis Due To Dynamic Clip-Leaflet Interaction During the MitraClip Procedure: Case Report and Review of Current Knowledge
The goal of MitraClip therapy is to achieve mitral regurgitation reduction without iatrogenic creation of clinically significant MS. In some series, up to 35% of patients are left with mild MS. There are many contributors to the final transmitral gradient achieved in patients undergoing MitraClip therapy. Additionally, there are many modalities used for the intraprocedural assessment of MS with no one modality considered to be the benchmark. We herein describe a case which illustrates the dynamic nature of clip-leaflet interaction, and review intraprocedural techniques for invasively and noninvasively assessing MS. (Source...
Source: Cardiovascular Revascularization Medicine - December 21, 2016 Category: Cardiology Authors: Gagan D. Singh, Thomas W. Smith, Jason H. Rogers Source Type: research

The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study
Stents reduce angiographic restenosis in comparison with balloon angioplasty. The rate of in-stent restenosis (ISR), although less frequent than post-angioplasty restenosis, is becoming increasingly prevalent due to the recent exponential increase in the use of intracoronary stents. The aim of this study is to evaluate angiographic and clinical outcomes of PTCA in combination with the use of excimer laser coronary angioplasty (ELCA) and drug-eluting balloon (DEB) in treatment of in-stent restenosis (ISR). (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 20, 2016 Category: Cardiology Authors: Vittorio Ambrosini, Luca Golino, Giampaolo Niccoli, Marco Roberto, Pasquale Lisanti, Roberto Ceravolo, Guglielmo Bernardi, Pietro Armigliato, Gabriele Gabrielli, Giuliano Chizzola, Concetta De Paulis, Filippo Crea, Antonio Colombo Source Type: research

The combined use of Drug Eluting Balloon and Excimer Laser for Coronary Artery Restenosis In Stent Treatment: The DERIST STUDY.
Stents reduce angiographic restenosis in comparison with balloon angioplasty [1, 2]. The rate of in-stent restenosis (ISR), although less frequent than post-angioplasty restenosis, is becoming increasingly prevalent due to the recent exponential increase in the use of intracoronary stents. Prior studies have shown that tubular slotted stents do not recoil and do not allow geometric arterial constriction, which may account for up to 55% of lumen loss in the restenotic process after angioplasty or atherectomy. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 20, 2016 Category: Cardiology Authors: Vittorio Ambrosini, Luca Golino, Giampaolo Niccoli, Marco Roberto, Pasquale Lisanti, Roberto Ceravolo, Guglielmo Bernardi, Pietro Armigliato, Gabriele Gabrielli, Giuliano Chizzola, Concetta De Paulis, Filippo Crea, Antonio Colombo Source Type: research

Combining Clinical and Angiographic Variables for Estimating Risk of Target Lesion Revascularization after Drug Eluting Stent Placement
Drug-eluting stents (DES) reduce restenosis but require prolonged antiplatelet therapy, when compared with bare metal stents. Ideally, the patient should be involved in this risk:benefit assessment prior to selecting DES, to maximize the benefits and cost-effectiveness of care, and to improve medication adherence. However, accurate estimation of restenosis risk may require angiographic factors identified at cardiac catheterization. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 16, 2016 Category: Cardiology Authors: Joshua M. Stolker, David J. Cohen, Kevin F. Kennedy, Michael J. Pencina, Suzanne V. Arnold, Neal S. Kleiman, John A. Spertus, EVENT Investigators Source Type: research

Impact of Robotics and a Suspended Lead Suit on Physician Radiation Exposure During Percutaneous Coronary Intervention
This study evaluated the impact of a suspended lead suit and robotic system on physician radiation exposure during percutaneous coronary intervention (PCI). (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 15, 2016 Category: Cardiology Authors: Ryan D. Madder, Stacie VanOosterhout, Abbey Mulder, Matthew Elmore, Jessica Campbell, Andrew Borgman, Jessica Parker, David Wohns Source Type: research

Transcatheter Aortic Valve Replacement for Bicuspid Aortic Stenosis 13Years Post Heart Transplant
Although bicuspid aortic valves (BAV) affect only 1 to 2% of the general population (1), up to 50% of adults with severe, symptomatic aortic stenosis undergoing surgical aortic valve replacement (AVR) may have BAV [1]. Given this frequency and the increasing survival for patients after orthotopic heart transplantation (OHT), it is important for clinicians to recognize the potential for aortic stenosis due to BAV in this population. There have been case reports of open AVR after cardiac transplant for BAV [2,3]. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 15, 2016 Category: Cardiology Authors: Maureen B. Julien, Nimesh Desai, Susan Brozena, Howard C. Herrmann Source Type: research

Zotarolimus-eluting Resolute Integrity versus everolimus-eluting Xience Xpedition stents in the management of very long ( > 30mm) de novo coronary artery stenosis
Procedural and clinical outcomes in patients with very long (>30mm) coronary lesions who underwent stent-based percutaneous coronary interventions are still unfavorable. Therefore, we compared the relative efficacy and safety of resolute zotarolimus-eluting stents (R-ZES) and Xpedition everolimus-eluting stents (X-EES) for patients with de novo very long coronary lesions. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 13, 2016 Category: Cardiology Authors: Soumya Patra, Rabindra Nath Chakraborty, Arindam Pande, Suvro Banerjee, Manabhanjan Jena, Prakash Chandra Mandal, Swapan Kumar De, Aftab Khan, Sankha Suvro Das, Debashish Ghosh, Raja Nag Source Type: research

Predicting Readmission Risk Following Percutaneous Coronary Intervention at the Time of Admission
To investigate whether a prediction model based on data available early in Percutaneous Coronary Intervention (PCI) admission can predict the risk of readmission. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 13, 2016 Category: Cardiology Authors: Zaher Fanari, Daniel Elliott, Carla A. Russo, Paul Kolm, William S. Weintraub Source Type: research

Association of remote ischemic peri-conditioning with reduced incidence of clinical heart failure after primary percutaneous coronary intervention
Clinical heart failure (HF) occurs frequently after ST-segment elevation myocardial infarction (STEMI), and is associated with increased mortality. We assessed the impact of remote ischemic peri-conditioning (RIPC) during inter-facility air medical transport of STEMI patients on clinical HF following primary percutaneous coronary intervention (pPCI). (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - December 13, 2016 Category: Cardiology Authors: Adetola Ladejobi, Max Wayne, Christian Martin-Gill, Francis X. Guyette, Andrew D. Althouse, Michael S. Sharbaugh, Steven E. Reis, Clifton Callaway, John A. Kellum, A.J. Conrad Smith, Catalin Toma, Oladipupo Olafiranye Source Type: research